3-dose of RBD vaccine is sufficient to elicit a long-lasting memory response against SARS-CoV-2 infection
Päätekijät: | , , , , , , , , , |
---|---|
Aineistotyyppi: | Artikkeli |
Kieli: | English |
Julkaistu: |
Nature Publishing Group
2022-03-01
|
Sarja: | Signal Transduction and Targeted Therapy |
Linkit: | https://doi.org/10.1038/s41392-022-00937-9 |